Professor Tom Scriba (PhD) directs the clinical immunology laboratory at the South African Tuberculosis Vaccine Initiative, University of Cape Town, South Africa. He trained in biological sciences at Stellenbosch University, South Africa, and obtained a DPhil (PhD) in T cell Immunology at Oxford University, UK. He returned to South Africa as a postdoctoral fellow in paediatric and clinical immunology in TB and trained in vaccinology at the Institute of Infectious Diseases and Molecular Medicine, University of Cape Town. Dr Scriba’s research focuses on TB vaccine development, immune correlates of protection against TB and biomarkers of risk of TB. His research is funded by competitive grants from the BMGF, the South African National Research Foundation (NRF), South African Medical Research Foundation, US National Institutes of Health and the European Union.